Contribution of oxidative stress and prostanoids in endothelial dysfunction induced by chronic fluoxetine treatment

Vascular Pharmacology

Volumn 73, Issue , 2015, Pages 124-137

  Simplicio, Janaina A ^a   Resstel, Leonardo B ^a   Tirapelli, Daniela P C ^a   D'Orléans Juste, Pedro ^b   Tirapelli, Carlos R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Endothelial dysfunction; Fluoxetine; Oxidative stress; Prostanoids; Vascular reactivity

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; ACETYLCHOLINE; CATALASE; CYCLOOXYGENASE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLUOXETINE; GLUTATHIONE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; PROSTANOID; SEROTONIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; THROMBOXANE B2; TIRON; ACETYLCHOLINESTERASE; ACHE PROTEIN, RAT; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MEMBRANE PROTEIN; NOS1 PROTEIN, RAT; PTGS1 PROTEIN, RAT; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; ISOLATED ARTERY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR RING; ANIMAL; AORTA; BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECTS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; TIME FACTOR; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; WISTAR RAT;

ACETYLCHOLINESTERASE; ANIMALS; AORTA; BLOOD PRESSURE; CATALASE; CYCLOOXYGENASE 1; DINOPROST; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FLUOXETINE; GPI-LINKED PROTEINS; HYDROGEN PEROXIDE; MALE; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE TYPE I; OXIDATIVE STRESS; RATS, WISTAR; SUPEROXIDE DISMUTASE; SUPEROXIDES; TIME FACTORS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 84941737187     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.06.015     Document Type: Article

References (48)

1. Bauer M., Whybrow P.C., Angst J., Versiani M., Möller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, part 1: acute and continuation treatment of major depressive disorder. World J. Biol. Psychiatry 2002, 3(1):5-43.
2. Spier S.A., Frontera M.A. Unexpected deaths in depressed medical in patients treated with fluoxetine. J. Clin. Psychiatry 1991, 52:377-382.
3. Ravina T., Suarez M.L., Mendez-Castrillon J. Fluoxetine-induced QTU interval prolongation, T wave alternans and syncope. Int. J. Cardiol. 1998, 65:311-313.
4. Roose S.P., Glassman A.H., Attia E., Woodring S., Giardina E.G., Bigger J.T. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am. J. Psychiatry 1998, 155:660-665.
5. Pacher P., Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?. Curr. Pharm. Des. 2004, 10:2463-2475.
6. Crestani C.C., Tavares R.F., Guimarães F.S., Correa F.M., Joca S.R., Resstel L.B. Chronic fluoxetine treatment alters cardiovascular functions in unanesthetized rats. Eur. J. Pharmacol. 2011, 670(2-3):527-533.
7. Ungvari Z., Pacher P., Kecskemeti V., Koller A. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel opener. Stroke 1999, 30:949-954.
8. i. J. Cardiovasc. Pharmacol. 2000, 35:849-854.
9. Montezano A.C., Touyz R.M. Reactive oxygen species and endothelial function - role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin. Pharmacol. Toxicol. 2012, 110(1):87-94.
10. Endemann D.H., Schiffrin E.L. Endothelial dysfunction. J. Am. Soc. Nephrol. 2004, 15:1983-1992.
11. Yaron I., Skirazi I., Judovich R., Levartovsky D., Caspi D., Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E-2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum. 1999, 42:2561-2568.
12. Crespi F. The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity?. Neurosci. Lett. 2010, 470:95-99.
13. Luo L., Tan R.X. Fluoxetine inhibits dendrite atrophy of hippocampal neurons by decreasing nitric oxide synthase expression in rat depression model. Acta Pharmacol. Sin. 2001, 22:865-870.
14. Göçmez S.S., Utkan T., Gacar N., Sarioglu Y. Chronic administration of fluoxetine impairs neurogenic and endothelium-dependent relaxation of the rabbit corpus cavernosum smooth muscle. Eur. J. Pharmacol. 2011, 670(1):224-228.
15. Laville N., Aït-Aïssa S., Gomez E., Casellas C., Porcher J.M. Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 2004, 196(1-2):41-55.
16. Alper R.H. Effects of the selective serotonin reuptake inhibitor fluoxetine on baroreceptor reflex sensitivity and body weight in young and old rats. J. Gerontol. 1992, 47:B130-B136.
17. Lino-de-Oliveira C., Sales A.J., Del Bel E.A., Silveira M.C., Guimaraes F.S. Effects of acute and chronic fluoxetine treatments on restraint stress-induced Fos expression. Brain Res. Bull. 2001, 55:747-754.
18. Tirapelli C.R., Fukada S.Y., Yogi A., Chignalia A.Z., Tostes R.C., Bonaventura D., Lanchote V.L., Cunha F.Q., de Oliveira A.M. Gender-specific vascular effects elicited by chronic ethanol consumption in rats: a role for inducible nitric oxide synthase. Br. J. Pharmacol. 2008, 153(3):468-479.
19. Yogi A., Callera G.E., Hipólito U.V., Silva C.R., Touyz R.M., Tirapelli C.R. Ethanol-induced vasoconstriction is mediated via redox-sensitive cyclo-oxygenase-dependent mechanisms. Clin. Sci. (Lond.) 2010, 118(11):657-668.
20. Yogi A., Callera G.E., Mecawi A.S., Batalhão M.E., Carnio E.C., Antunes-Rodrigues J., Queiroz R.H., Touyz R.M., Tirapelli C.R. Acute ethanol intake induces superoxide anion generation and mitogen-activated protein kinase phosphorylation in rat aorta: a role for angiotensin type 1 receptor. Toxicol. Appl. Pharmacol. 2012, 264(3):470-478.
21. Gonzaga N.A., Callera G.E., Yogi A., Mecawi A.S., Antunes-Rodrigues J., Queiroz R.H., Touyz R.M., Tirapelli C.R. Acute ethanol intake induces mitogen-activated protein kinase activation, platelet-derived growth factor receptor phosphorylation, and oxidative stress in resistance arteries. J. Physiol. Biochem. 2014, 70(2):509-523.
22. Gonzaga N.A., Mecawi A.S., Antunes-Rodrigues J., De Martinis B.S., Padovan C.M., Tirapelli C.R. Ethanol withdrawal increases oxidative stress and reduces nitric oxide bioavailability in the vasculature of rats. Alcohol 2015, 49(1):47-56.
23. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
24. Hussein S., Kaufman B.M. Bradycardia associated with fluoxetine in an elderly patient with sick sinus syndrome. Postgrad. Med. J. 1994, 70:56.
25. Ofek K., Schoknecht K., Melamed-Book N., Heinemann U., Friedman A., Soreq H. Fluoxetine induces vasodilatation of cerebral arterioles by co-modulating NO/muscarinic signalling. J. Cell. Mol. Med. 2012, 16(11):2736-2744.
26. Tabernero A., Giraldo J., Vila E. Modeling the changes due the endothelium and hypertension in the α-adrenoceptor-mediated response of the rat aorta. J. Auton. Pharmacol. 1999, 19:219-228.
27. Wong M.S., Delansorne R., Man R.Y., Svenningsen P., Vanhoutte P.M. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am. J. Physiol. Heart Circ. Physiol. 2010, 299(4):H1226-H1234.
28. Hayashi T., Fukuto J.M., Ignarro L.J., Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:11259-11263.
29. Silva B.R., Pernomian L., Grando M.D., Bendhack L.M. Phenylephrine activates eNOS Ser(1177) phosphorylation and nitric oxide signaling in renal hypertensive rat aorta. Eur. J. Pharmacol. 2014, 738:192-199.
30. Côrtes S.F., Andriantsitohaina R., Stoclet J.C. Alterations of cyclo-oxygenase products and NO in responses to angiotensin II of resistance arteries from the spontaneously hypertensive rat. Br. J. Pharmacol. 1996, 119(8):1635-1641.
31. Carrillo-Sepúlveda M.A., Ceravolo G.S., Fortes Z.B., Carvalho M.H., Tostes R.C., Laurindo F.R., Webb R.C., Barreto-Chaves M.L. Thyroid hormone stimulates NO production via activation of the PI3K/Akt pathway in vascular myocytes. Cardiovasc. Res. 2010, 85(3):560-570.
32. Kesavan M., Sarath T.S., Kannan K., Suresh S., Gupta P., Vijayakaran K., Sankar P., Kurade N.P., Mishra S.K., Sarkar S.N. Atorvastatin restores arsenic-induced vascular dysfunction in rats: modulation of nitric oxide signaling and inflammatory mediators. Toxicol. Appl. Pharmacol. 2014, 280(1):107-116.
33. Denniff M., Turrell H.E., Vanezis A., Rodrigo G.C. The time-of-day variation in vascular smooth muscle contractility depends on a nitric oxide signalling pathway. J. Mol. Cell. Cardiol. 2014, 66:133-140.
34. Tirapelli C.R., Leone A.F., Yogi A., Tostes R.C., Lanchote V.L., Uyemura A.S., Resstel L.B., Corrêa F.M., Padovan C.M., de Oliveira A.M., Coelho E.B. Ethanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in rats. J. Pharm. Pharmacol. 2008, 60(3):331-341.
35. Novella S., Dantas A.P., Segarra G., Vidal-Gómez X., Mompeón A., Garabito M., Hermenegildo C., Medina P. Aging-related endothelial dysfunction in the aorta from female senescence-accelerated mice is associated with decreased nitric oxide synthase expression. Exp. Gerontol. 2013, 48(11):1329-1337.
36. Jiménez-Altayó F., Onetti Y., Heras M., Dantas A.P., Vila E. Western-style diet modulates contractile responses to phenylephrine differently in mesenteric arteries from senescence-accelerated prone (SAMP8) and resistant (SAMR1) mice. Age (Dordr.) 2013, 35(4):1219-1234.
37. Chatterjee A., Black S.M., Catravas J.D. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc. Pharmacol. 2008, 49:134-140.
38. Xia Y., Zweier J.L. Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6954-6958.
39. Pagano P.J., Ito Y., Tornheim K., Gallop P.M., Tauber A.I., Cohen R.A. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am. J. Physiol. 1995, 268(6 Pt 2):H2274-H2280.
40. Pernomian L., Santos Gomes M., Baraldi Araujo Restini C., Naira Zambelli Ramalho L., Renato Tirapelli C., Maria de Oliveira A. The role of reactive oxygen species in the modulation of the contraction induced by angiotensin II in carotid artery from diabetic rat. Eur. J. Pharmacol. 2012, 678(1-3):15-25.
41. Silva B.R., Pernomian L., Grando M.D., Amaral J.H., Tanus-Santos J.E., Bendhack L.M. Hydrogen peroxide modulates phenylephrine-induced contractile response in renal hypertensive rat aorta. Eur. J. Pharmacol. 2013, 721(1-3):193-200.
42. Wong M.S., Vanhoutte P.M. COX-mediated endothelium-dependent contractions: from the past to recent discoveries. Acta Pharmacol. Sin. 2010, 31:1095-1102.
43. -.), superoxide dismutases, and related matters. J. Biol. Chem. 1997, 272:18515-18517.
44. Wei E.P., Kontos H.A., Beckman J.S. Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. Am. J. Physiol. 1996, 271(3 Pt 2):H1262-H1266.
45. Sato A., Sakuma I., Gutterman D.D. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am. J. Physiol. Heart Circ. Physiol. 2003, 285(6):H2345-H2354.
46. + channel activation. Circ. Res. 2012, 110(3):471-480.
47. Freinbichler W., Colivicchi M.A., Stefanini C., Bianchi L., Ballini C., Misini B., Weinberger P., Linert W., Varešlija D., Tipton K.F., Della Corte L. Highly reactive oxygen species: detection, formation, and possible functions. Cell. Mol. Life Sci. 2011, 68:2067-2079.
48. Gao Y.J., Hirota S., Zhang D., Janssen L.J., Lee R.M. Mechanisms of hydrogen peroxide-induced biphasic response in rat mesenteric artery. Br. J. Pharmacol. 2003, 138:1085-1092.